Featured Solutions

  1. The CRO Support You Need, When You Need It 2/11/2026

    Move your drug development forward with our flexible CRO support services, integrated seamlessly with your program to simplify execution and accelerate progress.

  2. Your Partner For Faster, More Advanced Phase 1 And 2 Trials 12/4/2025

    Early-phase clinical research experts, specialized in first-in-human trials, clinical pharmacology/NDA-enabling studies, and proof-of-concept studies. 

  3. Program Management 10/7/2025

    With Altasciences, a single program manager oversees your studies from preclinical to early-phase, streamlining communication, accelerating timelines, and reducing stress.

  4. Turnkey Solutions For Your Renal And Hepatic Impairment Studies 10/7/2025

    With three clinical pharmacology units, access to 145,000+ hepatic/renal patients, and 100+ completed studies, we’re your partner for NDA-enabling trials.

  5. Renal And Hepatic Impaired Study 8/21/2025

    Altasciences has completed over 100 renal and hepatic impairment studies via multiple routes of administration and offers comprehensive CRO services.

  6. Altasciences' CNS Center Of Excellence: Award-Winning Services 5/9/2025

    Recognized globally as a CNS Center of Excellence, Altasciences has completed more than 200 preclinical and clinical neurological studies, in addition to providing formulation, manufacturing, and analytical testing services, as well as bioanalytical support. Speak with one of their experts!

  7. Clinical Solutions For Early-Phase Drug Development 5/2/2025

    Altasciences provides deep expertise in all clinical pharmacology studies required for successful regulatory submission across a wide range of therapeutic areas.

     

    View the complete resource library.

     

    Contact an Altasciences expert to learn more about their comprehensive clinical solution.

  8. Two Regulatory Pathways — One Expert Partner 4/25/2025

    Whether you’re pursuing an IND submission in the U.S. or a CTA in Canada and Europe, our integrated solutions model provides comprehensive regulatory support at every drug development stage.

  9. Drug-Drug Interaction Clinical Trials 3/19/2025

    We specialize in DDI studies, including stand-alone and 'cocktail' designs, assessing multiple CYP enzymes or transporters in single studies, from simple crossovers to complex adaptive trials.

  10. Metabolic Disorders 10/8/2024

    Altasciences has over 25 years of experience in metabolic diseases and supports every stage of the development process, from discovery to clinical trials — and beyond.